Esculetin reduced lesion extension, and diarrhea incidence, and restored GSH levels in acute colitis, whereas 4-methyl-esculetin seemed to exert a superior efficacy, also inhibiting MPO and alkaline phosphatase activities, beneficial in acute and relapse colitis models likely due to its methyl group at C-4. Here, MPO is linked to colitis.